Assessing pharma's impact in Latin America

Innovative treatments and medicines developed by the pharmaceutical industry in Latin America not only save lives, but also create jobs, help reduce health spending and raise quality of life standards, The Pharma Letter’s local correspondent writes.

This is the conclusion of the Assessment of the Research-based Pharmaceutical Industry in Latin America, a study developed by the Latin American Federation of the Pharmaceutical Industry (Fifarma) and conducted by the IQVIA Institute for Human Data Science.

In this research, the contributions of companies in nine Latin American countries – namely Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama and Peru – were investigated, analyzing their economic, societal and human impact.